Thomas: No Conflicts of Interest with Bond Investment Firm
By Admin ~ July 1st, 2011 @ 11:07 pm
Jonathan Thomas, the newly elected chairman of the billion California stem cell agency, plans to continue his financial ties to a Southern California bond investment firm.
Thomas, who is being paid 0,000 annually by CIRM for four days of work each week, said no conflict of interest exists in his relationship with Saybrook Capital of Santa Monica, Ca. Thomas co-founded the firm and is
California Stem Cell Report
Subscribe to blog feed.
About the Author: